drugset / Trial / NCT02763007
An Extension Study of PEAK Trial
RandomizedParallel-groupOpen-labelTreatment
Summary
Double blind, three arm, comparative intervention trial for 24 weeks(PEAK study) with open label extension trial for 28 weeks followed by 2 year observational study.
Timeline
- Start
- 2016-05-18
- Primary completion
- 2018-12-19
- Completion
- 2019-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alogliptin | Unknown | 25 mg | — |
| Subject | Pioglitazone | Small molecule | 30 mg | — |